Clinico-biological Collection of Bone, Calcium and Growth Plate Pathologies

Creation of a Biological Collection to Study the Pathophysiology and Identify Predictive Factors for the Evolution of Bone, Calcium and Growth Plate Pathologies

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06444503

Acronym

OSCAR

Enrollment

350

Registered

2024-06-05

Start date

2024-09-16

Completion date

2034-09-16

Last updated

2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Disorder

Brief summary

The aim of this project is to set up a biological and clinical collection of patients with progressive bone, calcium and growth plate pathologies. This collection will provide a better understanding of the mechanisms involved in growth plate and bone damage in these diseases and identify factors predictive of progression and new therapeutic targets.

Interventions

OTHERBiological samples

Blood and urine will be taken in larger quantity

OTHERBiological

Surgical residues may be preserved in the event of surgery carried out as part of the treatment.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 99 Years

Healthy volunteers

Inclusion criteria

* Children (from birth) with growth plate or bone pathology * Patients affiliated to or benefiting from a social security scheme * Patients able to receive information about the study and to understand the information form in order to participate in the study. This implies : * mastery of the French language * Not being subject to a restriction of rights by the judicial authorities * Patients or legal representatives having given their consent to participate in the study (expression of non-opposition).

Exclusion criteria

* Patients under legal protection (guardianship, curatorship or safeguard of justice) * Pregnant or breast-feeding women

Design outcomes

Primary

Measure	Time frame	Description
Building a collection of biological samples and clinical-biological data from patients presenting bone, calcium and growth plate pathologies	Day 0 and through study completion, an average of 5 years	Blood and urine sampling

Secondary

Measure	Time frame
Identification of potential markers of disease progression based on new knowledge.	Day 0 and through study completion, an average of 5 years

Countries

France

Contacts

CONTACTThomas EDOUARD, MD

edouard.t@chu-toulouse.fr0534558555

CONTACTSanaa EDDIRY

eddiry.s@chu-toulouse.fr0561776110

PRINCIPAL_INVESTIGATORThomas EDOUARD, MD

University Hospital, Toulouse

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026